CDRE
Cadre Holdings, Inc. Health Care Orthopedic, Prosthetic & Surgical Appliances & Supplies Russell 3000
$30.36Close
$1.3BMarket cap
$24.47 – $45.7652-week range
Nov 4, 2026Next report · after the close
Highlights
Cautions
- Not in an uptrend 1 of 8 trend conditions
- Lagging the market RS 26 · weaker than 74% of stocks over 12 months
- Far from its high 34% below its 52-week high
- Earnings shrinking EPS −12% year on year
- Results soon Nov 4, 2026, in 3 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
34%
1wk
up 1.6%
price change
1mo
up 21.4%
price change
12-month return
down 28%
market up 11% ·
its own down 40%
F-score
6 / 9
Mixed
Altman Z
3.25
Low risk
P/E
29.0×
price / earnings
PEG
2.16
P/E / EPS growth
P/B
4.0×
price / book
Earnings yield
up 4.7%
EBIT / enterprise value
Cheaper than
55%
of the market · around average
Revenue growth
up 8%
year on year
EPS growth
down 12%
latest quarter · +68 pts
Sales growth
up 32%
latest quarter · +12 pts
ROE
up 14%
return on equity
Free cash margin
up 9%
$56.8M FCF
D/E
0.92
long-term debt / equity
Net debt / EBITDA
2.0×
Interest cover
—EBIT / interest
Piotroski tests
- profitability slipped from last year
- issued more shares
- assets working less efficiently
- profitable on its assets
- generating cash from operations
- profits backed by cash
- reduced long-term debt
- short-term liquidity improved
- gross margin widened
Repair signals
- Gross margin 41.1% → 42.5%
Trade setup
ATR%
3.9%
$1.17 a day · 2×ATR $28.02
RS
26 / 99
vs the universe
Trend
1 / 8
trend template
Relative volume
0.7×
vs 50-day average
Up/down volume
1.02
50 sessions
Implied move
—
no option chain · report Nov 4, 2026
Trend template · 1 of 8
- Price above the 50-day average: passes
Screen verdict
Did not qualify for any screen.
Warning signs
- Shareholders diluted The share count rose 3.8% over the year, from 41m to 42m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Aug 5, 2026
Results reaction
Aug 5, 2026+14% vs market2 sessions after results
Financials
- Gross 43%
- Net 7%
- Free cash 9%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $404.6M | $427.3M | $457.8M | $482.5M | $567.6M | $610.3M |
| Gross margin | 38% | 40% | 38% | 42% | 41% | 43% |
| Operating income | $49.8M | $51.7M | $16.7M | $56.5M | $66.8M | $67.4M |
| Net income | $38.5M | $12.7M | $5.8M | $38.6M | $36.1M | $44.1M |
| Net margin | 10% | 3% | 1% | 8% | 6% | 7% |
| Earnings per share | $1.40 | $0.44 | $0.16 | $1.02 | $0.90 | $1.02 |
| Free cash flow | $40.7M | $37.3M | $41.9M | $66.5M | $26.1M | $56.8M |
| Free cash margin | 10% | 9% | 9% | 14% | 5% | 9% |
| Cash | $2.9M | $33.9M | $45.3M | $87.7M | $124.9M | $122.9M |
| Long-term debt | $209.3M | $146.5M | $137.5M | $127.8M | $211.8M | $291.0M |
| Shareholders' equity | $8.9M | $88.6M | $165.9M | $197.2M | $311.5M | $317.8M |
| Shares outstanding | 27.48m | 34.38m | 37.33m | 37.59m | 40.61m | 42.16m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 5, 2026 | Quarterly ↗ | Jun 30, 2026 | 36d |
| May 11, 2026 | Quarterly ↗ | Mar 31, 2026 | 41d |
| Mar 10, 2026 | Annual ↗ | Dec 31, 2025 | 69d |
| Nov 4, 2025 | Quarterly ↗ | Sep 30, 2025 | 35d |
| Aug 5, 2025 | Quarterly ↗ | Jun 30, 2025 | 36d |
| May 6, 2025 | Quarterly ↗ | Mar 31, 2025 | 36d |
| Mar 11, 2025 | Annual ↗ | Dec 31, 2024 | 70d |
| Nov 6, 2024 | Quarterly ↗ | Sep 30, 2024 | 37d |
| Aug 9, 2024 | Quarterly ↗ | Jun 30, 2024 | 40d |
| May 8, 2024 | Quarterly ↗ | Mar 31, 2024 | 38d |
| Mar 12, 2024 | Annual ↗ | Dec 31, 2023 | 72d |
| Nov 8, 2023 | Quarterly ↗ | Sep 30, 2023 | 39d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 5, 2026 | Results ↗ |
| Jul 29, 2026 | Material agreement · New obligation ↗ |
| Jun 3, 2026 | Director or officer change · Shareholder vote ↗ |
| May 11, 2026 | Results ↗ |
| Mar 10, 2026 | Results ↗ |
| Nov 4, 2025 | Results ↗ |
| Nov 3, 2025 | Material agreement ↗ |
| Oct 29, 2025 | Regulation FD ↗ |
| Oct 8, 2025 | Regulation FD ↗ |
| Aug 5, 2025 | Results ↗ |
| Jun 5, 2025 | Director or officer change · Shareholder vote ↗ |
| May 6, 2025 | Results ↗ |